CircSLC39A8 attenuates paclitaxel resistance in ovarian cancer by regulating the miR‑185‑5p/BMF axis

Chemoresistance to paclitaxel (PTX) is one of the main reasons for treatment failure and poor prognosis in patients with advanced ovarian cancer. Therefore, it is imperative to explore the mechanisms related to chemotherapy resistance in ovarian cancer to find potential therapeutic targets. Circular...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yuwan, Shen, Zhangjin, Wei, Xinyi, Gu, Lingkai, Zheng, Mengxia, Zhang, Yanan, Cheng, Xiaodong, Fu, Yunfeng, Lu, Weiguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413200/
https://www.ncbi.nlm.nih.gov/pubmed/37499410
http://dx.doi.org/10.1016/j.tranon.2023.101746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413200/
https://www.ncbi.nlm.nih.gov/pubmed/37499410
http://dx.doi.org/10.1016/j.tranon.2023.101746

Ejemplares similares